Catalyst Wire Dossier Catalyst Wire Dossier

Pegylated Interferon-alpha2a

pegylated interferon alfa-2a
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pegylated Interferon-alpha2a, covering 2011-07-21 to 2011-07-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B [Phase 4]

See pricing